Despite cutting-edge vaccines and treatments, one of the most effective ways to stay on top of COVID-19 surges relies on a decidedly basic entity: human waste. Biobot, co-founded by Massachusetts Institute of Technology biologist Mariana Matus and urban-studies researcher Newsha Ghaeli, is the first company to analyze human waste—which can provide an early warning of an impending spike in COVID-19 cases—on a commercial basis. Its technology, which can detect pathogens as well as other substances of interest (like opioids), is now in use at more than 700 sewage sites serving more than 100 million people.
A weekly newsletter featuring conversations with the world’s top CEOs, managers, and founders. Join the Leadership Brief.
- Inside One Indian iPhone Factory
- Congress Avoided a Shutdown. What Happens Next?
- Global Climate Solutions Exist. It's Time to Deploy Them
- What Happens to Diane Feinstein's Senate Seat
- The Enduring Charm of John Grisham
- Who The Golden Bachelor Leaves Out
- Kerry Washington: The Story of My Abortion
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time